Caveat Oncologist: Clinical Findings and Consequences of Distributing Counterfeit Erythropoietin in the United States

PURPOSE: Counterfeit pharmaceuticals pose risks domestically. Because of their cost, cancer pharmaceuticals are vulnerable. We review findings from a domestic counterfeiting episode involving erythropoietin and outline anticounterfeiting recommendations for policy makers, patients, and health care p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Qureshi, Zaina P., Norris, LeAnn, Sartor, Oliver, McKoy, June M., Armstrong, John, Raisch, Dennis W., Garg, Vishvas, Stafkey-Mailey, Dana, Bennett, Charles Lee
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2012
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457834/
https://ncbi.nlm.nih.gov/pubmed/23077434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000325
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars